Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner
Why Neogen Stock Blasted More Than 31% Higher Today: https://g.foolcdn.com/editorial/images/850222/dog-looking-at-camera-with-its-mouth-open.jpg
Why Neogen Stock Blasted More Than 31% Higher Today

The stock of healthcare company Neogen (NASDAQ: NEOG) was the very picture of financial health on Thursday, as its share price ballooned by over 31% that trading session. Investors were clearly

Stock Market Today, Jan. 8: Nvidia Slides as AI Demand Forecasts Top $500 Billion: https://cdn.content.foolcdn.com/images/1umn9qeh/production/f034a43c32c50fe7f75e8747c51761cad74f0a9d-1400x1250.png?w=1400&h=1250
Stock Market Today, Jan. 8: Nvidia Slides as AI Demand Forecasts Top $500 Billion

Nvidia (NASDAQ:NVDA), a GPU and AI solutions leader, closed Thursday's session at $185, down 2.17%. Nvidia IPO'd in 1999 and has grown an astounding 450,934% since going public. Trading volume

Jensen Huang Just Delivered Brilliant News to Nvidia Investors for 2026: https://g.foolcdn.com/editorial/images/849808/gettyimages-1335027284.jpg
Jensen Huang Just Delivered Brilliant News to Nvidia Investors for 2026

Nvidia (NASDAQ: NVDA) has been an artificial intelligence (AI) champion since the start of the AI boom. The company got into the space early, focusing the design of its chips to suit this

This Under-the-Radar Tech Stock Is Making Me Thirsty ... to Buy Shares: https://g.foolcdn.com/editorial/images/850088/water-faucet-getty.jpg
This Under-the-Radar Tech Stock Is Making Me Thirsty ... to Buy Shares

Sometimes, the investing universe seems like it's upside down. Many of the largest consumer-facing companies make products that fall squarely in the nice-to-have category rather than being

Why Voyager Technologies Stock Soared Today: https://g.foolcdn.com/editorial/images/850122/futuristic-space-station-orbiting-earth.jpg
Why Voyager Technologies Stock Soared Today

Voyager Technologies (NYSE: VOYG) stock rocketed 8.1% through 11:15 a.m. ET Thursday on a double dose of good news. The biggest: President Trump announced Wednesday he wants to spend $1.5 trillion

Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks: https://g.foolcdn.com/editorial/images/849342/a-person-flipping-through-dollar-bills.jpg
Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks

Dividend stocks can be the ultimate investments to buy and forget about. They'll generate recurring income for your portfolio, even if you've forgotten you own them. What's important, however, is to

VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East
VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East
VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East
New Investors: 3 Stocks to Build Your Portfolio Around in 2026: https://g.foolcdn.com/editorial/images/849344/a-person-looking-at-a-chart-on-their-laptop.jpg
New Investors: 3 Stocks to Build Your Portfolio Around in 2026

If you're looking to get started with investing, there are many solid stocks you can put in your portfolio. Ideally, you'll want to start with some blue chip stocks to be pillars that you can hang

3 of the Best Stocks Under $100 to Buy in 2026: https://g.foolcdn.com/editorial/images/849343/an-excited-businessperson-looking-at-their-computer.jpg
3 of the Best Stocks Under $100 to Buy in 2026

Want some good, cheap stocks to buy for the new year? The ones that I've listed below all trade below $100 a share, are cheap with respect to their earnings, and offer a mix of value, dividends, and

Can These Dividend Stocks Beat the Market Again in 2026?: https://g.foolcdn.com/editorial/images/849565/pharmacist-talking-to-patient.jpg
Can These Dividend Stocks Beat the Market Again in 2026?

Last year was a rebound one for CVS Health (NYSE: CVS) and Amgen (NASDAQ: AMGN). After underperforming broader equities in 2024, both healthcare giants bounced back in 2025, outperforming the market

2 Healthcare Stocks to Buy for 2026 and Beyond: https://g.foolcdn.com/editorial/images/849524/pharmacist-talking-to-patient.jpg
2 Healthcare Stocks to Buy for 2026 and Beyond

The healthcare sector underperformed broader equities in 2025, but that shouldn't deter investors. Many companies in the industry performed relatively well and appear to be solid buy-and-hold

Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026?: https://g.foolcdn.com/editorial/images/847556/pfizer_logo_on_glass_pfe.jpg
Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026?

A rising tide doesn't lift all boats. For example, a boat with gaping holes in its hull will sink regardless of how high the tide rises. Pfizer (NYSE: PFE) seemed to be the investing equivalent of

EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Why Super Micro Computer Stock Fell In December: https://g.foolcdn.com/editorial/images/849920/super-computer.jpg
Why Super Micro Computer Stock Fell In December

Shares of Super Micro Computer (NASDAQ: SMCI) sank 13.5% in December, according to data from S&P Global Market Intelligence. As an assembler of advanced computer chips for data center providers, the

Should AMD Stock Investors Be Worried After the Company's Latest Keynote Announcements Failed to Impress the Market?: https://g.foolcdn.com/editorial/images/849930/charts-18.png
Should AMD Stock Investors Be Worried After the Company's Latest Keynote Announcements Failed to Impress the Market?

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD) and other AI stocks. To learn more, check out the short video, consider subscribing, and click the special

3 Drug Stocks to Buy at a Discount: https://g.foolcdn.com/editorial/images/849526/23_11_28-a-finger-flipping-dice-that-spell-out-long-term-and-short-term-_mf-dload-gettyimages-1134479990-1369x800-60dadfc.jpg
3 Drug Stocks to Buy at a Discount

Over short periods, Wall Street is largely driven by emotions. When there's a compelling story, such as the emergence of GLP-1 weight loss drugs in the pharmaceutical sector, investors tend to

This Could Be Key to Pfizer's Turnaround in 2026: https://g.foolcdn.com/editorial/images/849334/a-group-of-scientists-looking-at-a-report.jpg
This Could Be Key to Pfizer's Turnaround in 2026

Did you know that in just the past three years, healthcare giant Pfizer (NYSE: PFE) has lost approximately half its value? The stock surged during the pandemic as its COVID-19 vaccine and pill

How Oddity Tech Could Break Out in 2026: https://g.foolcdn.com/editorial/images/849809/beauty-products-getty.jpg
How Oddity Tech Could Break Out in 2026

The beauty and wellness industry operates largely on an old-economy model in which manufacturers sell products wholesale to retailers that are then responsible for figuring out how best to sell

EQS-News: Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
EQS-News: Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
EQS-News: Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
Why UnitedHealth Stock Bumped Higher Today: https://g.foolcdn.com/editorial/images/849791/child-receiving-a-vaccination-shot-from-a-healthcare-professional.jpg
Why UnitedHealth Stock Bumped Higher Today

This is the time of year when market professionals and investors alike pore over lists of top analyst stock picks. One big company that appeared in such a lineup was UnitedHealth (NYSE: UNH), and in

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib: https://cdn.content.foolcdn.com/images/1umn9qeh/production/e3bcbb36c955ac33b4d67641805fcca8e9fca941-1401x1251.png?w=1401&h=1251
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib

Alumis (NASDAQ:ALMS), which develops targeted therapies for immune-mediated diseases, closed Tuesday’s session at $16.23, up 95.31%. Trading volume reached 64.1 million shares, coming in about

Why Stryker Stock Popped Today: https://g.foolcdn.com/editorial/images/849691/woman-in-chair-surrounded-by-question-marks-under-a-large-red-arrow-trending-down.jpg
Why Stryker Stock Popped Today

Stryker (NYSE: SYK) stock is hopping Tuesday morning, up 3.2% through 11:45 a.m. ET, after Raymond James analyst Jayson Bedford called the company "one of the highest quality stocks in large cap

Why AngioDynamics Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/849675/hand-with-images-of-question-marks.jpg
Why AngioDynamics Stock Is Sinking Today

Shares of AngioDynamics (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open.

EQS-News: Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
EQS-News: Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
EQS-News: Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent